Evidence map›Paper›PMID 37711619›Full record

ArticleFrontiers in immunology2023

Changes in subcutaneous white adipose tissue cellular composition and molecular programs underlie glucose intolerance in persons with HIV.

Samuel S Bailin, Jonathan A Kropski, Rama D Gangula, LaToya Hannah, Joshua D Simmons, Mona Mashayekhi, Fei Ye, Run Fan, Simon Mallal, Christian M Warren and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Samuel S BailinDepartment of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
Jonathan A KropskiDepartment of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Rama D GangulaTennessee Center for AIDS Research, Vanderbilt University Medical Center, Nashville, TN, United States.
LaToya HannahDepartment of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, TN, United States.
Joshua D SimmonsTennessee Center for AIDS Research, Vanderbilt University Medical Center, Nashville, TN, United States.
Mona MashayekhiDepartment of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, TN, United States.
Fei YeDepartment of Biostatics, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Run FanDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, United States.
Simon MallalDepartment of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
Christian M WarrenTennessee Center for AIDS Research, Vanderbilt University Medical Center, Nashville, TN, United States.
Spyros A KalamsDepartment of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
Curtis L GabrielDepartment of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Nashville, TN, United States.
Celestine N WanjallaDepartment of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
John R KoetheDepartment of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
Vanderbilt University Medical Center · USVanderbilt University · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Tennessee CFAR: Implementation of Culturally Responsive Trauma-Informed Care with Youth with HIV in Memphis, TNP30AI110527 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI John Koethe · 2015 to 2026
$27.5M
Training In Cardiovascular Physiology & PharmacologyT32HL007444 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ju Chen, Robert Scott Ross · 1985 to 2026
$11.1M
Institutional Career Development CoreKL2TR002245 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julie A. Bastarache · 2017 to 2026
$9.3M
Vanderbilt Infection Pathogenesis and Epidemiology Research Training ProgramT32AI007474 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KALAMS, SPYROS A · 1995 to 2025
$6.9M
Spatiotemporal genomic regulation of disease initiation and progression in pulmonary fibrosisR01HL145372 · NHLBI · TRANSLATIONAL GENOMICS RESEARCH INST · PI Nicholas Eli Banovich, Jonathan Andrew Kropski · 2019 to 2026
$6.0M
Pathophysiology of Metabolically Detrimental Changes in Adipose Distribution, Adipocyte Function, and Adipose Immune Environment on Antiretroviral TherapyR01DK131529 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHEILA COLLINS, John Koethe · 2022 to 2026
$4.2M
The Role of Adipose-Resident T Cells in HIV-Associated Glucose IntoleranceR01DK112262 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KOETHE, JOHN · 2017 to 2021
$3.8M
UCSD PRIDE Faculty Development Program in Cardiovascular SciencesR25HL145817 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Robert Scott Ross, Joann Trejo · 2019 to 2026
$3.3M
Vanderbilt SCHolars in HIV and Heart, Lung, Blood, and Sleep ReSearch (V-SCHoLARS, K12)K12HL143956 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FREIBERG, MATTHEW S, KOETHE, JOHN · 2018 to 2022
$1.6M
Anti-cytomegalovirus Immune Responses in Atherosclerotic Cardiovascular Disease in Persons Living with HIVK23HL156759 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WANJALLA, CELESTINE N · 2021 to 2025
$860k
NCATS NIH HHS KL2 TR002245NCRR NIH HHS UL1 RR024975NHLBI NIH HHS K12 HL143956NHLBI NIH HHS K23 HL156759NHLBI NIH HHS R01 HL145372NHLBI NIH HHS R25 HL145817NHLBI NIH HHS T32 HL007444NIAID NIH HHS P30 AI110527NIAID NIH HHS T32 AI007474NIDDK NIH HHS K23 DK135414NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK112262NIDDK NIH HHS R01 DK131529
6 · The paper itself

Abstract

Introduction: Subcutaneous adipose tissue (SAT) is a critical regulator of systemic metabolic homeostasis. Persons with HIV (PWH) have an increased risk of metabolic diseases and significant alterations in the SAT immune environment compared with the general population. Methods: We generated a comprehensive single-cell multi-omic SAT atlas to characterize cellular compositional and transcriptional changes in 59 PWH across a spectrum of metabolic health. Results: Glucose intolerance was associated with increased lipid-associated macrophages, CD4 Discussion: These findings suggest a central role of tissue-resident immune cells in regulating SAT inflammation among PWH with metabolic disease, and underscore unique mechanisms that may converge to promote metabolic disease.

Indexed as

Glucose IntoleranceHIV InfectionsHumansInflammationLipidsSubcutaneous FatLipidsglucose intolerancehuman immunodeficiency virusimmune cellssingle-cell RNA sequencingsubcutaneous adipose tissuetype 2 diabetes mellituswhite adipose tissue

Identifiers

PMID37711619
PMCPMC10499182
OpenAlexW4386309189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.